Waqar Aman

2.1k total citations · 1 hit paper
30 papers, 1.5k citations indexed

About

Waqar Aman is a scholar working on Pharmaceutical Science, Molecular Biology and Organic Chemistry. According to data from OpenAlex, Waqar Aman has authored 30 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pharmaceutical Science, 9 papers in Molecular Biology and 5 papers in Organic Chemistry. Recurrent topics in Waqar Aman's work include Advanced Drug Delivery Systems (10 papers), Drug Solubulity and Delivery Systems (7 papers) and Advancements in Transdermal Drug Delivery (4 papers). Waqar Aman is often cited by papers focused on Advanced Drug Delivery Systems (10 papers), Drug Solubulity and Delivery Systems (7 papers) and Advancements in Transdermal Drug Delivery (4 papers). Waqar Aman collaborates with scholars based in Pakistan, South Korea and Saudi Arabia. Waqar Aman's co-authors include Fakhar ud Din, Alam Zeb, Izhar Ullah, Shumaila Shafique, Omer Mustapha, Omer Salman Qureshi, K Thomä, Jung‐Mi Hah, Jung-Hun Lee and Jin‐Ki Kim and has published in prestigious journals such as SHILAP Revista de lepidopterología, International Journal of Pharmaceutics and European Journal of Pharmacology.

In The Last Decade

Waqar Aman

30 papers receiving 1.5k citations

Hit Papers

Effective use of nanocarriers as drug delivery systems fo... 2017 2026 2020 2023 2017 250 500 750 1000

Peers

Waqar Aman
Waqar Aman
Citations per year, relative to Waqar Aman Waqar Aman (= 1×) peers Annalisa Cutrignelli

Countries citing papers authored by Waqar Aman

Since Specialization
Citations

This map shows the geographic impact of Waqar Aman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Waqar Aman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Waqar Aman more than expected).

Fields of papers citing papers by Waqar Aman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Waqar Aman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Waqar Aman. The network helps show where Waqar Aman may publish in the future.

Co-authorship network of co-authors of Waqar Aman

This figure shows the co-authorship network connecting the top 25 collaborators of Waqar Aman. A scholar is included among the top collaborators of Waqar Aman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Waqar Aman. Waqar Aman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Aman, Waqar, Rabia Arshad, Abbas Rahdar, et al.. (2024). Progression in nano-botanical oral hygiene solutions: The Dawn of biomimetic nanomaterials. SHILAP Revista de lepidopterología. 12. 100219–100219. 4 indexed citations
2.
Ali, Nayab, Rabia Arshad, Waqar Aman, et al.. (2024). Advanced wound healing: The synergy of nature and nanotechnology. Journal of Drug Delivery Science and Technology. 105. 106579–106579. 3 indexed citations
3.
Ghazy, Esraa, Rabia Arshad, Waqar Aman, et al.. (2024). Novel thiolated pluronic anchored gastro-retentive SEDDS of azithromycin against peptic ulcer. Inorganic Chemistry Communications. 167. 112755–112755. 3 indexed citations
4.
Salawi, Ahmad, Muhammad Zaman, Tehseen Riaz, et al.. (2022). Development of Statistically Optimized Chemically Cross-Linked Hydrogel for the Sustained-Release Delivery of Favipiravir. Polymers. 14(12). 2369–2369. 19 indexed citations
5.
Shah, Fawad Ali, Imran Malik, Fakhar ud Din, et al.. (2022). Formulation optimization, in vitro and in vivo evaluation of agomelatine-loaded nanostructured lipid carriers for augmented antidepressant effects. Colloids and Surfaces B Biointerfaces. 216. 112537–112537. 30 indexed citations
6.
Khan, Muhammad Imran, Vahid Nikoui, Faiza Mumtaz, et al.. (2021). Antidepressant-like effect of ethanol in mice forced swimming test is mediated via inhibition of NMDA/nitric oxide/cGMP signaling pathway. Alcohol. 92. 53–63. 11 indexed citations
7.
Baseer, Abdul, Syed Saoud Zaidi, Muhammad Waseem Khan, et al.. (2021). Fluconazole-loaded thermosensitive system: In vitro release, pharmacokinetics and safety study. Journal of Drug Delivery Science and Technology. 67. 102972–102972. 32 indexed citations
8.
Khan, Namrah, Fawad Ali Shah, Isra Rana, et al.. (2020). Nanostructured lipid carriers-mediated brain delivery of carbamazepine for improved in vivo anticonvulsant and anxiolytic activity. International Journal of Pharmaceutics. 577. 119033–119033. 82 indexed citations
9.
Nikoui, Vahid, Saeed Mehrzadi, Muhammad Imran Khan, et al.. (2020). Licofelone, a dual cyclooxygenase/5-lipoxygenase inhibitor, reverses endotoxin-induced impaired atrial chronotropic responsiveness to cholinergic stimulation in rats. European Journal of Pharmacology. 887. 173569–173569. 1 indexed citations
10.
Hussain, Sajid, Farhat Ullah, Muhammad Ayaz, et al.. (2019). <p>In Silico, Cytotoxic and Antioxidant Potential of Novel Ester, 3-hydroxyoctyl -5- <em>trans</em>-docosenoate Isolated from <em>Anchusa arvensis</em> (L.) M.Bieb. Against HepG-2 Cancer Cells</p>. Drug Design Development and Therapy. Volume 13. 4195–4205. 14 indexed citations
11.
Kim, Jinwoong, et al.. (2019). Computer-aided design and synthesis of 3-carbonyl-5-phenyl-1H-pyrazole as highly selective and potent BRAFV600E and CRAF inhibitor. Journal of Enzyme Inhibition and Medicinal Chemistry. 34(1). 1314–1320. 10 indexed citations
12.
Aman, Waqar, et al.. (2017). Novel scaffold evolution through combinatorial 3D-QSAR model studies of two types of JNK3 inhibitors. Bioorganic & Medicinal Chemistry Letters. 27(10). 2139–2143. 11 indexed citations
13.
Waris, Abdul, et al.. (2017). Physicochemical Modifications and Nano Particulate Strategies for Improved Bioavailability of Poorly Water Soluble Drugs. Pharmaceutical Nanotechnology. 5(4). 276–284. 11 indexed citations
14.
Aman, Waqar, et al.. (2016). Discovery of highly selective CRAF inhibitors, 3-carboxamido-2H-indazole-6-arylamide: In silico FBLD design, synthesis and evaluation. Bioorganic & Medicinal Chemistry Letters. 26(4). 1188–1192. 48 indexed citations
15.
Jung, Kyungjin, et al.. (2015). Discovery of 4-arylamido 3-methyl isoxazole derivatives as novel FMS kinase inhibitors. European Journal of Medicinal Chemistry. 102. 600–610. 27 indexed citations
16.
Kim, Minjung, Jung-Hun Lee, Kyungjin Jung, et al.. (2014). Design, synthesis and biological evaluation of benzyl 2-(1H-imidazole-1-yl) pyrimidine analogues as selective and potent Raf inhibitors. Bioorganic & Medicinal Chemistry Letters. 24(15). 3600–3604. 14 indexed citations
17.
Park, Yunjeong, et al.. (2014). Click approach to the discovery of 1,2,3-triazolylsalicylamides as potent Aurora kinase inhibitors. Bioorganic & Medicinal Chemistry. 22(17). 4855–4866. 10 indexed citations
18.
Aman, Waqar & K Thomä. (2004). How to photostabilize molsidomine tablets**This article is dedicated to the memory of Prof. Dr. K. Thoma.. Journal of Pharmaceutical Sciences. 93(7). 1860–1866. 4 indexed citations
19.
Aman, Waqar & K Thomä. (2003). Particular features of photolabile substances in tablets.. PubMed. 58(9). 645–50. 9 indexed citations
20.
Aman, Waqar & K Thomä. (2002). The influence of formulation and manufacturing process on the photostability of tablets. International Journal of Pharmaceutics. 243(1-2). 33–41. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026